David Lisle, MD
Colon & Rectal Surgery · Baltimore, MDNPI 1457645848
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $839 of the $1,149 with a category attached, or 73.0%. 6 manufacturers reported payments, led by Intuitive Surgical at 37.6% of the total. Reporting peaked in 2024 at $476 and has fallen 58.2% since, to $199 in 2025. That places this record below the midpoint for colon & rectal surgery clinicians in MD, where the typical reported total is $1,789.
Across 26 payments — averaging $44.20 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intuitive Surgical$432
- Johnson & Johnson$398
- Boston Scientific$115
- Stryker$93
- Medtronic$82
- Pentax Of America, Inc.$30
What the payments were for
- Travel & lodging$31027%
- Food & beverage$83973%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intuitive Surgical | 4 | $432 |
| Johnson & Johnson(2 entities) | 15 | $398 |
| Boston Scientific | 1 | $115 |
| Stryker | 1 | $93 |
| Medtronic | 4 | $82 |
| Pentax Of America, Inc. | 1 | $30 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Da Vinci Surgical System$291
- CRE PRO$115
How this compares
$1,149 in reported general payments places this provider in the 30th percentile of 29 colon & rectal surgery providers in Maryland.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Neomycin Sulfate | 31 | $141 |
| Metronidazole | 33 | $61 |
| Oxycodone Hcl | 12 | $28 |
Paid to pharmacies, not to this prescriber.
Other colon & rectal surgery in Baltimore
- Irina BernescuBaltimore$93K
- Bashar SafarBaltimore$26K
- Joshua WolfBaltimore$24K
- Philip FerrisBaltimore$11K
- Chady AtallahBaltimore$4K
- Wei LiuBaltimore$2K
- Evan BuckinghamBaltimore$2K
- Joann WarrickBaltimore$437
- Kathryn ChuBaltimore$41
- Ivane ChuaTowson$10K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.